HRTX Stock Analysis: Buy, Sell, or Hold?
HRTX - Heron Therapeutics, Inc.
$1.32
-0.02 (-1.49%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When HRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HRTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: HRTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: HRTX is currently trading at $1.32, which is considered fair relative to its 30-day fair value range of $1.28 to $1.46.
Technical Outlook: Technically, HRTX is in a strong downtrend. The price is currently testing key support at $1.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.50 (+235.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HRTX is in a strong downtrend. The price is currently testing key support at $1.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.50 (+235.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.28 -
$1.46
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Protect Your Profits
Holding HRTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 235.8% below Wall St target ($4.50)
- CAUTION: Recommendation downgraded due to -7.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.28 -
$1.46
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.31
Resistance Level
$1.52
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-26.80
Wall Street Target
$4.50
(+235.8%)
Revenue Growth (YoY)
16.5%
Profit Margin
-8.8%
Last updated: January 31, 2026 12:35 PM ET
Data refreshes hourly during market hours. Next update: 1:35 PM
Data refreshes hourly during market hours. Next update: 1:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HRTX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Adam Morgan
BUY
1766546 shares
2025-08-08
Rubric Capital Managemen…
BUY
2387225 shares
2025-08-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced HRTX Option Strategies
Professional options setups generated by AI based on today's HRTX price and gamma walls.
